Man Donates Bikes To Children
Posted on : 07-19-2016 By : Samantha Pointer
Dennis Baker is a senior citizen who doesn't take any time off to enjoy retirement. Instead, he has fun refurbishing bikes for children who are in need. He has repaired and donated bikes for over 10 years, and he is still going strong so that he can see a smile on the face of a child who might not have a bike to ride. Most of the bikes are donated to the Lower Mainland Christmas Bureau. He works for about three hours every day, making sure that each bike is…
Read More
0 Comments
Andy Wirth Discusses How The Drought Affected Squaw Valley Resort
Posted on : 07-15-2016 By : Samantha Pointer
On a recent episode of KCRW's Press Play With Madeline Brand, Squaw Valley Holdings CEO and President Andy Wirth discussed "How the Drought Will Affect California Resorts." Recent history hasn't been good to the California ski community. Drought conditions hit the area hard and a number of businesses have yet to bounce back. When asked about the recent drought and how his resort fared, Wirth made it clear that that last couple of years have been no picnic by any means. "We were hit with what Stanford scientists call the…
Read More
0 Comments
The Innovative Vision of Clay Siegall and Seattle Genetics
Posted on : 07-13-2016 By : Samantha Pointer
  Seattle Genetics is a company working on revolutionizing cancer therapy. At the head of that revolution is co-founder and CEO Dr. Clay Siegall. For the past 17 years, Seattle Genetics, under Dr. Siegall’s leadership, has worked to create breakthrough concepts in cancer therapies through the research and development of antibody-drug conjugates, or ADC’s. ADC’s are a targeted therapy in the treatment of cancer, inhibiting the growth of cancerous cells without damaging the body’s healthy cells like traditional chemotherapy. Seattle Genetics dedication and tireless research continue to innovate and show encouraging progress in antibody-drug conjugates. Through Dr. Siegall’s guidance and direction, Seattle Genetics technological advances have contributed to the development of more than 20 ADC’s. Siegall, a graduate of the University of Maryland, and George Washington University is committed to the company’s growth and continued research. Thanks to his vigorous efforts, he has managed to secure more than 675 million dollars through private and public funding. International partnerships have also contributed to the company’s growth and assets. Dr. Siegall is proud of the research and technologies Seattle Genetics has created in its crusade against cancer. The company’s ADCETRIS, a new class of ADC’s, has shown positive results in more than 15,000 lymphoma patients in the U.S and abroad. About half of the patients that undergo autologous stem cell transplant face the threat of relapsing. Seattle Genetics is working to develop new therapies that would reduce the risk and increase the patient’s chances of a successful recovery. With their dedication, continued research, and fundraising, Dr. Siegall, and Seattle Genetics will continue to lead the way in cancer treatment innovation. Read about Clay: http://www.seattlegenetics.com/clay_siegall
Read More
0 Comments
Kabbalah Offers Freedom
Posted on : 07-06-2016 By : Samantha Pointer
A deeper purpose of life can be discovered through the ancient wisdoms of the Kabbalah. Understanding the nature of the universe and the purpose for being are the principal concepts. People who practice the Kabbalah find fulfillment in all aspects of their life including relationships, health, and achieving future goals. Each important element stems from the same foundation. Looking to the universe for answers to life’s difficult questions is the path on which the principles of the Kabbalah are based. It provides the tools that are needed to find success…
Read More
0 Comments
Sam Tabar Makes Waves In Law and Business
Posted on : 07-06-2016 By : Samantha Pointer
Sam Tabar has distinguished himself greatly in the fields of law and business. Few people have matched his achievements. As an attorney and a capital strategist, he knows how to keep his clients happy. He began his career at Skadden, Arps, Slater, Meagher & Flom LLP, and he was chosen by that firm to serve as an Associate due to his great business acumen. His work there focused on capital strategy and business development. Now he works with the FullCycle Fund in the teeming metropolis of New York City. Formerly,…
Read More
0 Comments
1 3 4 5 6